Albuterol Sulfate
Product Images NDC 67296-1863

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 67296-1863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL Carton Label (Image 01)

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by Mylan. The carton contains 5 pouches of 5 sterile unit-dose vials each. The label includes dosage strength, application for inhalation only, and pharmacist instructions. NDC 0378-7057-52 is visible.*

FDA Label Image

Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL Carton Label (Image 02)

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Mylan. The carton indicates sterile unit-dose vials, with a package containing 5 pouches of 5 x 3 mL vials each. The label includes dosing concentration and usage instructions specifying inhalation only.*

FDA Label Image

Albuterol Sulfate Structural Formula (Image 03)

Chemical structure of albuterol sulfate, showing the molecular arrangement including hydroxyl groups, aromatic ring, and side chains along with sulfate ions as indicated. The structure is relevant to the active ingredient in Albuterol Sulfate products by RedPharm Drug.*

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Image 04)

A line graph depicting percentage change over time (hours from pre-dose) for treatments of albuterol 1.25 mg, albuterol 0.63 mg, and placebo. Three distinct lines represent each treatment's % change from 0 to 6 hours post-dose, showing comparative trends between doses and placebo.*

FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Image 05)

A line graph showing the percent change over hours from pre-dose for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The x-axis represents time in hours from pre-dose, ranging from 0 to 6 hours, while the y-axis represents percent change. The graph illustrates the comparative effect of the two albuterol doses and placebo over time.*

FDA Label Image

Instructions For Use Figure 1 (Image 06)

Illustration showing a dropper dispensing liquid into a small container with a funnel, positioned under a faucet. The figure is labeled as Figure 1, likely demonstrating a step for preparation or dosing related to Albuterol Sulfate.*

FDA Label Image

Instructions For Use Figure 2 (Image 07)

An instructional diagram showing a person holding and preparing an Albuterol Sulfate inhaler. The image depicts one hand pressing down on the inhaler mouthpiece while the other hand holds the inhaler body, illustrating usage technique or dose preparation for the inhaler device.*

FDA Label Image

Instructions For Use Figures 3 And 4 (Image 08)

An instructional illustration depicting two steps in using a respiratory inhaler device. The left image shows a person placing the mouthpiece into their mouth for inhalation. The right image shows the person using the inhaler while holding the device and a spacer, demonstrating proper inhalation technique.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.